Systemic lupus erythematosus (SLE) is a spontaneously occurring, chronic autoimmune disease that can manifest neuropsychiatric abnormalities. The pathways mediating these central changes are not known; however, neuroendocrine alterations associated with inflammation may play a role. Predisposition to and progression of autoimmune disease has been associated with altered hypothalamic-pituitary-adrenal (HPA) function and inflammation has been reported to alter hypothalamic regulation of HPA responses. We investigated whether disease progression in a murine model of systemic lupus erythematosus (MRL ϩ/ϩ. MRL lpr/lpr) resulted in altered expression of HPA regulatory peptides at the level of the hypothalamus and how these alterations related to circulating levels of corticosterone, corticosterone binding globulin, and autoantibody titers. We report that as MRL ϩ/ϩ and MRL lpr/lpr mice age and circulating levels of autoantibodies increase, there is a decrease in hypothalamic CRH mRNA expression and finally an increase in AVP mRNA expression. We also report that associated with increased autoantibody levels, disease progression, and altered hypothalamic peptide expression there is an increase in circulating levels of corticosterone and a trend for levels of corticosterone binding globulin to decrease. Our data complement previous observations of altered peptidergic regulation of the HPA axis and increased HPA activity during chronic inflammation in exogenously induced rodent models of chronic inflammation and indicate that similar processes may occur in spontaneous murine models of SLE.
INTRODUCTION
Systemic lupus erythematosus (SLE) is a spontaneously occurring chronic autoimmune disease of humans and some animals, where both genetic and exogenous factors are thought to contribute to the manifestations of disease. The disease is characterized by the appearance of particular patterns of autoantibodies and although the clinical tempo varies widely, renal, cutaneous, hematological, and joint disease are typical, while neurobehavioral abnormalities are also a frequent but enigmatic feature.
Of the murine models of SLE, the MRL/lpr and NZB/WF1 hybrids are particularly well studied. In these, as in the human disease, autoantibodies develop to a variety of nuclear, cytoplasmic, and cell surface components. Certain autoantibodies (anti-DNA, anti-Sm) are pathogenic in both the renal and the cutaneous abnormalities, largely by immune complex deposition and recruitment of an inflammatory cascade (Bloom, Davingnon, Cohen, Eisenberg, & Clarke, 1993; Isenberg, 1997; Pisetsky, 1993; Vlahakos, Foster, Adams, Katz, Ucci, Barrett, Datta, & Madaio, 1992) . Other autoantibodies exert their effects by binding to cognate antigens on the surfaces of platelets and lymphocytes resulting in thrombocytopenia and leukopenia. Autoantibodies may play a role in determining neuropsychiatric abnormalities, however, despite associations of several autoantibodies with learning disorders and emotional
